Hansoh Pharmaceutical Group Co. Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The board comprises Executive Directors Ms. Zhong Huijuan (Chairlady and Chief Executive Officer), Ms. Sun Yuan, and Dr. Lyu Aifeng. Independent Non-executive Directors include Mr. Lin Guoqiang, Mr. Chan Charles Sheung Wai, Ms. Yang Dongtao, and Mr. Yan Jia. The company has established five board committees. Ms. Zhong Huijuan serves as Chairlady of the Strategy and Development Committee and the Nomination Committee, and is a member of the Remuneration Committee. Dr. Lyu Aifeng is Chairman of the Environmental, Social and Governance Committee and a member of the Strategy and Development Committee. Mr. Lin Guoqiang sits on the Audit, Remuneration, and Nomination Committees. Mr. Chan Charles Sheung Wai is Chairman of the Audit Committee and a member of the Strategy and Development, Environmental, Social and Governance, and Nomination Committees. Ms. Yang Dongtao chairs the Remuneration Committee and is a member of the Audit, Strategy and Development, and Environmental, Social and Governance Committees. Mr. Yan Jia is a member of the Audit and Environmental, Social and Governance Committees.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251228-11967869), on December 28, 2025, and is solely responsible for the information contained therein.
Comments